Nov 06, 2024 / 09:30PM GMT
Operator
Good day. And thank you for standing by. Welcome to the Revolution Medicines Q3 2024 earnings conference call.
(Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your first speaker today, Ryan Asay, senior Vice President of Corporate Affairs. Please go ahead.
Ryan Asay - Revolution Medicines Inc - Senior Vice President, Corporate Affairs
Thank you and welcome everyone to the third quarter, 2024 earnings call. Joining me on today's call are Dr Mark Goldsmith Revolution Medicines, Chairman and Chief Executive Officer, Dr Steve Kelsey, our President of R&D and Jack Andrews, our Chief Financial Officer, Doctor Way Lin, our Chief Medical Officer will join us for the Q&A portion of today's call. I'd like to inform you that certain statements we make during this call will be forward-looking because such statements deal with future events and are subject to many risks and uncertainties.
Actual results may differ materially from those in the forward
Q3 2024 Revolution Medicines Inc Earnings Call Transcript
1 day ago
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers